Search

everythinglearnresearchcommunity

for

Search:↓

Both oral contraceptives reduced acne effectively and had similar positive effects on skin oiliness and hair growth.

SAHA syndrome is a condition in women involving skin and hair issues, often related to hormonal imbalances, and is treated based on the underlying cause.

Finasteride reduces hairiness and androgen levels in women with unexplained excessive hair growth.

Women with acromegaly often have irregular periods due to hormone imbalances and growth hormone effects.

A combination of desogestrel and ethinyl oestradiol effectively reduces hair growth in hirsute women.

Acne severity is linked to higher levels of certain androgenic hormones, even when those levels are within the normal range.

Androgens play a complex role in skin conditions like acne and hair loss in women, and normal blood levels don't always show true androgen status.

Androgens like testosterone affect hair growth and oil production differently across body parts and individuals.

Low-dose oral contraceptives reduced hair growth and testosterone levels in women with polycystic ovary syndrome.

Women with Polycystic Ovary Syndrome have higher levels of the hormone ghrelin, which may be linked to the cause of the condition.

Testosterone is linked to cardiovascular risk factors and stroke, but its exact role is unclear.

Antiandrogen therapy helped increase hair growth in women with hormonal imbalances related to baldness.

Steroid-binding globulins have important roles beyond just transporting steroids.

Finasteride and CPA-EE2 equally reduce hirsutism, but affect hormone levels differently.

Women with only irregular periods or excess hair have a better hormone profile than those with full PCOS, but both groups are similar, indicating a need for better PCOS diagnosis methods.

The document concludes that treating PCOS requires a combination of drugs to manage reproductive and metabolic symptoms, with more research needed on combination therapies.

People with hair loss have higher risk of high blood sugar and diabetes, and lower levels of a specific hormone.

Women with female pattern hair loss have higher levels of certain androgens, suggesting increased androgen exposure to hair follicles.

Certain genetic variations are linked to increased androgen levels in PCOS, but more research is needed to understand these connections fully.

Men with early balding often have hormone levels similar to women with polycystic ovary syndrome.

Early onset baldness in men may indicate a condition similar to PCOS, linked to heart disease, diabetes, and prostate issues.

Women with PCOS have unhealthy changes in their cholesterol particles that are not related to their body weight.

Menopausal women have higher androgen levels, which can cause symptoms like facial hair growth and low sexual desire.

Premature balding in some men may be linked to altered hormones, but it's not the male equivalent to polycystic ovary syndrome or metabolic syndrome.

Most patients improved with oral contraceptives, but some needed additional treatment.

Oophorectomy lowers testosterone and estrogen levels in both premenopausal and postmenopausal women, with postmenopausal women still producing significant testosterone.

Most patients experienced hirsutism again after stopping hormone treatment, indicating long-term treatment is needed to maintain results.

Hormonal contraceptives can help treat acne by affecting sebum production and androgen levels.

The combined Myo-inositol and D-chiro-inositol treatment improved weight, hormone levels, and skin conditions in women with PCOS.

Older men with low levels of a testosterone byproduct had a higher chance of developing an irregular heartbeat.